vs

Side-by-side financial comparison of CF Industries (CF) and Everus Construction Group, Inc. (ECG). Click either name above to swap in a different company.

CF Industries is the larger business by last-quarter revenue ($1.9B vs $1.0B, roughly 1.9× Everus Construction Group, Inc.). CF Industries runs the higher net margin — 26.4% vs 5.5%, a 21.0% gap on every dollar of revenue. On growth, Everus Construction Group, Inc. posted the faster year-over-year revenue change (33.2% vs 22.8%). CF Industries produced more free cash flow last quarter ($313.0M vs $23.5M). Over the past eight quarters, Everus Construction Group, Inc.'s revenue compounded faster (27.1% CAGR vs 12.8%).

CF Industries Holdings, Inc. is an American manufacturer and distributor of agricultural fertilizers, including ammonia, urea, and ammonium nitrate products. The company is based in Northbrook, Illinois, a suburb of Chicago, and was founded in 1946 as the Central Farmers Fertilizer Company. For its first 56 years, it was a federation of regional agricultural supply cooperatives. CF then demutualized, and became a publicly traded company.

CF vs ECG — Head-to-Head

Bigger by revenue
CF
CF
1.9× larger
CF
$1.9B
$1.0B
ECG
Growing faster (revenue YoY)
ECG
ECG
+10.3% gap
ECG
33.2%
22.8%
CF
Higher net margin
CF
CF
21.0% more per $
CF
26.4%
5.5%
ECG
More free cash flow
CF
CF
$289.5M more FCF
CF
$313.0M
$23.5M
ECG
Faster 2-yr revenue CAGR
ECG
ECG
Annualised
ECG
27.1%
12.8%
CF

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CF
CF
ECG
ECG
Revenue
$1.9B
$1.0B
Net Profit
$495.0M
$55.3M
Gross Margin
40.9%
11.6%
Operating Margin
33.0%
6.8%
Net Margin
26.4%
5.5%
Revenue YoY
22.8%
33.2%
Net Profit YoY
26.3%
60.4%
EPS (diluted)
$2.56
$1.09

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CF
CF
ECG
ECG
Q4 25
$1.9B
$1.0B
Q3 25
$1.7B
$986.8M
Q2 25
$1.9B
$921.5M
Q1 25
$1.7B
$826.6M
Q4 24
$1.5B
$759.6M
Q3 24
$1.4B
$761.0M
Q2 24
$1.6B
$703.4M
Q1 24
$1.5B
$625.7M
Net Profit
CF
CF
ECG
ECG
Q4 25
$495.0M
$55.3M
Q3 25
$460.0M
$57.0M
Q2 25
$492.0M
$52.8M
Q1 25
$351.0M
$36.7M
Q4 24
$392.0M
$34.5M
Q3 24
$341.0M
$41.8M
Q2 24
$506.0M
$39.0M
Q1 24
$238.0M
$28.2M
Gross Margin
CF
CF
ECG
ECG
Q4 25
40.9%
11.6%
Q3 25
38.1%
12.6%
Q2 25
39.9%
13.0%
Q1 25
34.4%
11.2%
Q4 24
34.4%
11.4%
Q3 24
32.4%
11.8%
Q2 24
43.2%
12.6%
Q1 24
27.8%
11.9%
Operating Margin
CF
CF
ECG
ECG
Q4 25
33.0%
6.8%
Q3 25
35.0%
7.3%
Q2 25
34.3%
7.9%
Q1 25
27.4%
6.2%
Q4 24
28.9%
6.1%
Q3 24
26.6%
7.1%
Q2 24
40.6%
7.3%
Q1 24
20.6%
6.2%
Net Margin
CF
CF
ECG
ECG
Q4 25
26.4%
5.5%
Q3 25
27.7%
5.8%
Q2 25
26.0%
5.7%
Q1 25
21.1%
4.4%
Q4 24
25.7%
4.5%
Q3 24
24.9%
5.5%
Q2 24
32.2%
5.5%
Q1 24
16.2%
4.5%
EPS (diluted)
CF
CF
ECG
ECG
Q4 25
$2.56
$1.09
Q3 25
$2.19
$1.11
Q2 25
$2.37
$1.03
Q1 25
$1.85
$0.72
Q4 24
$1.86
$0.68
Q3 24
$1.55
$0.82
Q2 24
$2.30
$0.76
Q1 24
$1.03
$0.55

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CF
CF
ECG
ECG
Cash + ST InvestmentsLiquidity on hand
Total DebtLower is stronger
$3.2B
$281.5M
Stockholders' EquityBook value
$4.8B
$629.8M
Total Assets
$14.1B
$1.7B
Debt / EquityLower = less leverage
0.66×
0.45×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CF
CF
ECG
ECG
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
$553.0K
Q2 24
Q1 24
Total Debt
CF
CF
ECG
ECG
Q4 25
$3.2B
$281.5M
Q3 25
$3.0B
$285.1M
Q2 25
$3.0B
$288.6M
Q1 25
$3.0B
$292.1M
Q4 24
$3.0B
$295.6M
Q3 24
$3.0B
Q2 24
$3.0B
Q1 24
$3.0B
Stockholders' Equity
CF
CF
ECG
ECG
Q4 25
$4.8B
$629.8M
Q3 25
$4.8B
$573.0M
Q2 25
$5.0B
$514.4M
Q1 25
$4.8B
$460.2M
Q4 24
$5.0B
$422.6M
Q3 24
$5.2B
$453.3M
Q2 24
$5.5B
$490.0M
Q1 24
$5.4B
$464.3M
Total Assets
CF
CF
ECG
ECG
Q4 25
$14.1B
$1.7B
Q3 25
$14.2B
$1.6B
Q2 25
$13.8B
$1.5B
Q1 25
$13.3B
$1.4B
Q4 24
$13.5B
$1.3B
Q3 24
$13.8B
$1.3B
Q2 24
$13.8B
Q1 24
$13.9B
Debt / Equity
CF
CF
ECG
ECG
Q4 25
0.66×
0.45×
Q3 25
0.61×
0.50×
Q2 25
0.60×
0.56×
Q1 25
0.62×
0.63×
Q4 24
0.60×
0.70×
Q3 24
0.57×
Q2 24
0.54×
Q1 24
0.55×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CF
CF
ECG
ECG
Operating Cash FlowLast quarter
$539.0M
$48.2M
Free Cash FlowOCF − Capex
$313.0M
$23.5M
FCF MarginFCF / Revenue
16.7%
2.3%
Capex IntensityCapex / Revenue
12.1%
2.4%
Cash ConversionOCF / Net Profit
1.09×
0.87×
TTM Free Cash FlowTrailing 4 quarters
$1.8B
$90.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CF
CF
ECG
ECG
Q4 25
$539.0M
$48.2M
Q3 25
$1.1B
$76.2M
Q2 25
$563.0M
$25.3M
Q1 25
$586.0M
$7.1M
Q4 24
$420.0M
Q3 24
$931.0M
$78.9M
Q2 24
$475.0M
Q1 24
$445.0M
$21.9M
Free Cash Flow
CF
CF
ECG
ECG
Q4 25
$313.0M
$23.5M
Q3 25
$717.0M
$65.7M
Q2 25
$318.0M
$12.3M
Q1 25
$454.0M
$-11.4M
Q4 24
$223.0M
Q3 24
$792.0M
$60.9M
Q2 24
$391.0M
Q1 24
$347.0M
$12.6M
FCF Margin
CF
CF
ECG
ECG
Q4 25
16.7%
2.3%
Q3 25
43.2%
6.7%
Q2 25
16.8%
1.3%
Q1 25
27.3%
-1.4%
Q4 24
14.6%
Q3 24
57.8%
8.0%
Q2 24
24.9%
Q1 24
23.6%
2.0%
Capex Intensity
CF
CF
ECG
ECG
Q4 25
12.1%
2.4%
Q3 25
20.9%
1.1%
Q2 25
13.0%
1.4%
Q1 25
7.9%
2.2%
Q4 24
12.9%
Q3 24
10.1%
2.4%
Q2 24
5.3%
Q1 24
6.7%
1.5%
Cash Conversion
CF
CF
ECG
ECG
Q4 25
1.09×
0.87×
Q3 25
2.31×
1.34×
Q2 25
1.14×
0.48×
Q1 25
1.67×
0.19×
Q4 24
1.07×
Q3 24
2.73×
1.89×
Q2 24
0.94×
Q1 24
1.87×
0.77×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CF
CF

Ammonia$591.0M32%
UAN$493.0M26%
Urea$372.0M20%
Other$244.0M13%
Other Products$147.0M8%
Ammonium Nitrate Segment$25.0M1%

ECG
ECG

Commercial$594.5M59%
Utility$203.5M20%
Industrial$82.8M8%
Institutional$66.1M7%
Service And Other$28.4M3%
Transportation$24.2M2%
Renewables$19.8M2%

Related Comparisons